[Influence of previous hepatitis B virus infection on liver fibrosis in patients with chronic hepatitis C: a retrospective case series evaluation].

INTRODUCTION Hepatitis C is a major cause of liver disease worldwide. Its evolutionary course is dynamics and may be influenced by several cofactors. Among them, previous hepatitis B virus infection (anti-HBcAg [+] and HBsAg [-]) has been associated with worse histological and therapeutic prognosis. This study had the objective of independently assessing the relationship between previous hepatitis B infection and liver fibrosis in patients with chronic hepatitis C. METHODS The medical records of patients chronically infected with the hepatitis C virus who had been seen consecutively during a one-year period at the infectious and parasitic diseases outpatient clinic of HC FMUSP were retrospectively reviewed in relation to epidemiological, clinical and histological data. Analysis on the independence of the previous hepatitis B infection was performed using the statistical model of multivariate logistic regression. Detection of anti-HBcAg was taken to be the independent variable. The outcome was taken to be grade 3 and 4 histopathological abnormality (septa with nodule formation and cirrhosis). RESULTS 145 subjects were evaluated in this study. 47.2% of them were anti-HBcAg (+). The main risk factor for infection was blood and blood derivative transfusion (35.9%). Findings of anti-HBcAg (+) were not related to advanced liver fibrosis, although piecemeal necrosis has been found frequently in patients with this serological marker. CONCLUSIONS Previous hepatitis B infection does not seem to increase the structural liver damage triggered by chronic hepatitis C virus infection, after statistical control for other co-factors capable to impact the natural history of this infection.

[1]  R. Carvalho-Filho,et al.  Clinical and histological impact of previous hepatitis B virus infection in patients with chronic hepatitis C , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[2]  J. Bartolomé,et al.  Occult hepatitis B virus and hepatitis C virus infections , 2008, Reviews in medical virology.

[3]  M. Dehesa-Violante,et al.  Epidemiology of hepatitis virus B and C. , 2007, Archives of medical research.

[4]  J. Koskinas,et al.  Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients , 2006, Hepatology.

[5]  Antonio Aguilera Guiraoa,et al.  Epidemiologa y manifestaciones clnicas de las hepatitis virales , 2006 .

[6]  Viv Bewick,et al.  Statistics review 14: Logistic regression , 2005, Critical care.

[7]  J. Pawlotsky Pathophysiology of hepatitis C virus infection and related liver disease. , 2004, Trends in microbiology.

[8]  M. Daikoku,et al.  Hepatitis B virus of genotype C persistence after recovery from acute hepatitis B virus infection in Japan. , 2003, Hepatology research : the official journal of the Japan Society of Hepatology.

[9]  T. Poynard,et al.  The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C , 2003, Journal of viral hepatitis.

[10]  R. Testa,et al.  Previous hepatitis B virus infection is associated with worse disease stage and occult hepatitis B virus infection has low prevalence and pathogenicity in hepatitis C virus‐positive patients , 2003, Liver international : official journal of the International Association for the Study of the Liver.

[11]  B. Rehermann Immune Responses in Hepatitis B Virus Infection , 2003, Seminars in liver disease.

[12]  A. Zanella,et al.  Peripheral blood count abnormalities among patients with hepatitis C in the United States , 2002, Hepatology.

[13]  A. Zanella,et al.  Peripheral blood count abnormalities among patients with hepatitis C in the United States , 2002, Hepatology.

[14]  D. Valla,et al.  Cigarette smoking and hepatic lesions in patients with chronic hepatitis C , 2001, Hepatology.

[15]  S. Litwin,et al.  Kinetics of Hepadnavirus Loss from the Liver during Inhibition of Viral DNA Synthesis , 2001, Journal of Virology.

[16]  S. Hanauer,et al.  The impact of previous HBV infection on the course of chronic hepatitis C , 2000 .

[17]  R. Idilman,et al.  The impact of previous HBV infection on the course of chronic hepatitis C , 2000, American Journal of Gastroenterology.

[18]  G. Raimondo,et al.  Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. , 1999, The New England journal of medicine.

[19]  F. A. Lopes,et al.  Avaliação clínico-epidemiológica prospectiva de candidatos a doadores de sangue anti-HCV reagentes , 1999 .

[20]  A. Mason,et al.  Molecular basis for persistent hepatitis B virus infection in the liver after clearance of serum hepatitis B surface antigen , 1998, Hepatology.

[21]  F. Chisari,et al.  The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T–lymphocyte response , 1996, Nature Medicine.

[22]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[23]  E. Sagnelli,et al.  Diagnosis and clinical impact of occult hepatitis B infection in patients with biopsy proven chronic hepatitis C: a multicenter study. , 2008, Journal of medical virology.

[24]  G. Raimondo,et al.  Occult hepatitis B virus infection. , 2007, Journal of hepatology.

[25]  H. Tillmann,et al.  Isolated anti-HBV core phenotype in anti-HCV-positive patients is associated with hepatitis C virus replication. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[26]  M. Shiffman Chronic Hepatitis C , 2004, Seminars in liver disease.

[27]  Basílio de Bragança Pereira,et al.  A curva ROC para testes diagnósticos , 2003 .

[28]  F. Chisari,et al.  Hepatitis B virus persistence after recovery from acute viral hepatitis. , 1994, The Journal of clinical investigation.